Wilbur Ross’s SPAC to Take Biotech Aprinoia Public

Ross Acquisition Corp. II

Aprinoia Therapeutics, which is studying drugs for Alzheimer’s and Parkinson’s diseases, is going public through a deal with Wilbur Ross’s SPAC. The deal with Ross Acquisition Corp. II values the combined company at about $320 million including debt.

Read more on Bloomberg…

Shanda Consult has been working with SPACs for many years, and our network of SPAC executives has deep experience in the sector. If you need to learn more about how to successfully use a SPAC structure and perhaps wish to set up your own SPAC, we are here to help.

Please contact us with any questions you may have.